HER2 Expression Detection and Radionuclide Therapy in Breast Cancer Using 99mTc/188Re Labeled Single Domain Antibody
Clinical trial NCT04674722 · COMPLETED
Trial details
- NCT number
- NCT04674722
- Sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-24
- Primary completion
- 2024-05-08
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.